Schistosomiasis epidemiology and control: how did we get here and where should we go?


Sturrock, RF; (2001) Schistosomiasis epidemiology and control: how did we get here and where should we go? Memorias do Instituto Oswaldo Cruz, 96 Suppl. pp. 17-27. ISSN 0074-0276

Full text not available from this repository.

Abstract

Although a disease of great antiquity, scientific studies of schistosomiasis began only 150 years ago. The complete life-cycle was not described until just before the First World War, making it possible at last to plan proper community control programmes. Inadequate tools prevented their effective implementation until well after the Second World War when new tools became available, thanks to the newly formed World Health Organization. Molluscicides spearheaded control programmes until the late 1970s but were then replaced by the newly developed, safe drugs still used today. Whatever the method used, the initial goal of eradication was, in the light of experience and cost, gradually replaced by less ambitious targets; first to stop transmission and then to reduce morbidity. The most successful programmes combined several methods to minimise reinfection after chemotherapy. Comparisons between different programmes are difficult without using appropriate, standardised diagnostic techniques and the correct epidemiological measurements. Some examples will be presented, mainly from our studies on Schistosoma mansoni in Kenya. Drug resistance on a scale comparable with malaria has not occurred in schistosomiasis but the likely withdrawal of all drugs except praziquantel leaves its control extremely vulnerable to this potential problem. An effective, affordable vaccine for use in endemic countries is unlikely to be ready for at least 5 years, and developing strategies for its use could take a further decade or more, judging from experience with drugs and molluscicides. In the interim, by analogy with malaria, the most cost-effective approach would the use of drugs combined with other methods to stop transmission, including molluscicides. The cost of molluscicides needs to be reduced and fears allayed about their supposedly adverse ecological effects.

Item Type: Article
Keywords: Adolescent, Adult, Animal, Anthelmintics/therapeutic use, Child, Child, Preschool, Human, Infant, Infant, Newborn, Kenya, National Health Programs, Praziquantel/therapeutic use, Prevalence, Schistosoma/drug effects, Schistosomiasis/drug therapy/*epidemiology/*prevention & control, Snails/drug effects, Adolescent, Adult, Animal, Anthelmintics, therapeutic use, Child, Child, Preschool, Human, Infant, Infant, Newborn, Kenya, National Health Programs, Praziquantel, therapeutic use, Prevalence, Schistosoma, drug effects, Schistosomiasis, drug therapy, epidemiology, prevention & control, Snails, drug effects
Faculty and Department: Faculty of Infectious and Tropical Diseases > Dept of Disease Control
PubMed ID: 11586422
Web of Science ID: 171200700003
URI: http://researchonline.lshtm.ac.uk/id/eprint/16272

Statistics


Download activity - last 12 months
Downloads since deposit
0Downloads
331Hits
Accesses by country - last 12 months
Accesses by referrer - last 12 months
Additional statistics for this record are available via IRStats2

Actions (login required)

Edit Item Edit Item